PMC Biogenix Announces Price Increase on Certain Product Lines

MEMPHIS, Tenn.–(BUSINESS WIRE)–PMC Biogenix Inc. announces that effective December 1, 2020 or as otherwise consistent with current written contracts, prices for products sold under the trademarks Armoslip®, Hystrene®, Industrene®, Kemamide®, Kemester®, and Lubrazinc® will be increased by 5 – 15% depending upon grade.

Customers with questions should contact their sales manager for further information.

ABOUT PMC

PMC Group is a US based growth oriented, diversified, global chemicals and pharmaceuticals company dedicated to innovative solutions to every need in a broad range of end markets including, plastics, consumer products, electronics, coatings, packaging, mining, personal care, food, automotive and pharmaceuticals. The company was built on a sustainable model of growth through innovation while promoting social good. PMC operates from a global manufacturing, innovation, and marketing platform with facilities in the Americas, Europe and Asia. More information about PMC and its activities around the world can be found at www.pmc-group.com.

Contacts

Allen Miskowiec 901-325-4943

amiskowiec@pmc-group.com
Customer Service 800-641-2152

Fax 800-641-2153

Powered by WPeMatico

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

For the last half century, thousands of communications professionals have turned to us to deliver their news to the audiences most important to their business through the sources they trust most. Over that time, we've gone from a single office with one full time employee to more than 500 employees in 32 bureaus.